Johnson & Johnson announced on Friday that it has offered Abbott Laboratories $4.325 billion in cash for eye health unit Abbott Medical Optics. The company announced in a statement that the deal will be “modestly accretive immediately to adjusted earnings per share.” The transaction is expected to close in the first quarter of next year. … Continue reading “Johnson & Johnson (JNJ) Wants To Spend $4.325B On This”
